Joseph H. Korn - Concepedia

Author

Joseph H. Korn

Boston University

Also Known As

J H Korn, J. H Korn, Joseph H Korn, Joseph H. Korn, Joseph Korn

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Boston University University of Connecticut United States Department of Veterans Affairs Boston Medical Center UConn Health

About

Joseph H. Korn is an author at Boston University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	924
2	Biochemistry	2	2	64
3	Engineering	1	1	33
4	Natural Sciences	1	1	31
5	Allergy	1	1	28

Joseph H. Korn

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192 Christopher P. Denton, Peter A. Merkel, Daniel E. Furst, Arthritis & Rheumatism	2006	449
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon Peter A. Merkel, Karen Herlyn, Richard W. Martin, Arthritis & Rheumatism	2002	326
Recombinant Human Relaxin in the Treatment of Scleroderma James R. Seibold, Joseph H. Korn, Robert W. Simms, Annals of Internal Medicine	2000	266
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study Fredrick M. Wigley, Joseph H. Korn, Mary Ellen Csuka, Arthritis & Rheumatism	1998	196
Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosis Ante Jelaska, Joseph H. Korn Arthritis & Rheumatism	2000	160
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double‐blind, placebo‐controlled trial Dinesh Khanna, Philip J. Clements, Daniel E. Fürst, Arthritis & Rheumatism	2009	152
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. Dinesh Khanna, Daniel E. Fürst, Philip J. Clements, PubMed	2005	150
Differential Regulation of Cyclooxygenases 1 and 2 by Interleukin-1β, Tumor Necrosis Factor-α, and Transforming Growth Factor-β1 in Human Lung Fibroblasts Arturo Díaz, Kenneth P. Chepenik, Joseph H. Korn, Experimental Cell Research	1998	147
Durometry for the assessment of skin disease in systemic sclerosis Eugene Y. Kissin, Aileen M. Schiller, Rondi B. Gelbard, Arthritis Care & Research	2006	138
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial Peter A. Merkel, Nancy Silliman, Christopher P. Denton, Arthritis Care & Research	2008	128

Page 1